Comprehensive approach to managing hidradenitis suppurativa patients.
Comprehensive approach to managing hidradenitis suppurativa patients.
复制标题
DOI：
10.1111/ijd.14870
复制
发表时间：
2020-06
影响因子：
3.6
通讯作者：
Naik HB
中科院分区：
文献类型：
--
作者：
Collier EK;Hsiao JL;Shi VY;Naik HB
化脓性汗腺炎（HS）是一种毁灭性的疾病，会造成巨大的健康相关生活质量（QoL）损害。1最近一项对异质性人群患者样本的回顾性分析报告称，美国HS患病率为0.1%。2然而，由于延迟获得护理、认识不足、误诊和延迟诊断而导致的报告不足可能会错误地降低真实患病率。延迟的HS诊断和分散的护理导致患者沮丧和对医疗保健系统的不信任。HS患者也增加了对高成本环境的利用，如急诊科和住院部。3 HS是一种具有多种合并症的复杂疾病4，因此需要专门和全面的护理。作者指导美国主要学术医疗中心的化脓性汗腺炎专科诊所。在此，我们为执业皮肤科医生提出了优化与HS患者临床接触的策略，以及对开发HS专业诊所感兴趣的皮肤科医生（图1）。
Hidradenitis suppurativa (HS) is a devastating disease that imparts enormous health-related quality of life (QoL) impairment. 1 A recent retrospective analysis of a heterogeneous population-based patient sample reported the US prevalence of HS to be 0.1%. 2 However, under-reporting due to delayed access to care, under-recognition, misdiagnosis, and delayed diagnosis may falsely lower the true prevalence. Delayed HS diagnosis and fragmented care lead to patient frustration and distrust of the healthcare system. HS patients also have increased utilization of high-cost settings, such as the emergency department and inpatient units. 3 HS is a complex disease with multiple comorbidities4 and thus requires specialized and comprehensive care. The authors direct hidradenitis suppurativa specialty clinics at major US academic medical centers. Herein we propose strategies for a practicing dermatologist to optimize clinical encounters with HS patients, as well as for dermatologists interested in developing an HS specialty clinic (Fig. 1).
影响因子：
168.9
作者：
Huang, Chaolin;Wang, Yeming;Cao, Bin
通讯作者：
Cao, Bin
DOI：
10.3760/cma.j.issn.0253-2727.2020.0006
发表时间：
2020-04-14
影响因子：
--
作者：
Zhang, Y;Cao, W;Li, T S
通讯作者：
Li, T S